Wiener Gesundheitsverbund, Klinik Hietzing

Vienna 1130

3 studies enrolling now · 6 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Non-Small Cell Lung Cancer, End Stage Kidney Disease, Fallopian Tube Cancer, Leukemia, Myeloid, Acute, Metastatic Non-Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer, Sjogrens Syndrome

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• Nipocalimab in Moderate to Severe Sjogren's Disease — Running, not enrolling
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early
• Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia — Stopped early